Histone deacetylase inhibitors sensitize cancer cells to...

Details Histone deacetylase inhibitors sensitize cancer cells to... Histone deacetylase inhibitors sensitize cancer cells to...

A - Human Necessities

61

K

A61K 31/435 (2006.01)

Patent

CA 2600845

Disclosed is the use of a combination of histone deacetylase inhibitors and epidermal growth factor receptor (EGFR) inhibitors to treat cancer.

L'invention concerne l'utilisation d'une combinaison d'inhibiteurs d'histone déacétylase et d'inhibiteurs du facteur de croissance épidermique (EGFR) aux fins de traitement de cancer.

Affiliated with

Also associated with

Rating

Histone deacetylase inhibitors sensitize cancer cells to... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Histone deacetylase inhibitors sensitize cancer cells to..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Histone deacetylase inhibitors sensitize cancer cells to... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1888427